COMP <GO>
CNXC vs NVDA // RSI-14 & 200D SMA MOMENTUM
Concentrix Corporation (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: CNXC 3
— NVDA 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CNXC
LAST: $30.34 (-0.62%) • MKT CAP: $1.85B
rsi-technicals
54.3
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
rsi-technicals
51.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNXC VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNXC | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.00% | 74.67% | -39.67 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.40% | 65.06% | -75.46 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 23.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.58% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -9.30% | 65.21% | -74.51 | NVDA | /operating-margins <GO> |
| Net Profit Margin | -13.00% | 63.66% | -76.66 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 83.38% | -81.18 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.83% | 0.02% | +4.81 | CNXC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.85 | 19.52 | -18.67 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | CNXC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 54.3 | 51.1 | +3.22 | CNXC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.85B | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNXC REV | NVDA REV | CNXC GROSS % | NVDA GROSS % | CNXC FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $9.83B | $130.50B | 35.0% | 75.0% | $572.5M | $60.85B |
| FY 2024 | $9.62B | $60.92B | 35.9% | 72.7% | $428.7M | $27.02B |
| FY 2023 | $7.11B | $26.97B | — | 56.9% | $678.0M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNXC // BETA —
NVDA // BETA 2.04